I n this chapter, a simple and sensitive spectrophotometric method for the determination of some vicinal dihydroxybenzene derivatives in pure and pharmaceutical preparations is described.
LITERATURE SURVEY
In view of the wide applications of catecholamines, convenient and reliable analytical methods are necessary for their assay. Many analytical techniques viz., HPLC4'5, voltammetric6 and liquid chromatographic7 have been reported for their assay. But, these techniques are of high cost and are not available at most of the pharmaceutical laboratories. However, spectrophotometric methods are particularly attractive because of their simplicity, reliability and low cost. Hence, many spectrophotometric methods have been reported for the determination of these drugs. Other spectrophotometric methods17'29 reported for the assay of catecholamines are presented in Table 3 .1a. It is evident from the table that most of the reagents employed by different researchers suffer from limitations in one or the other way such as heating17'19'25, extraction20,29, long standing22 29, or lack of sensitivity21,24,27,28.
However, no efforts are made so far to study the reaction of the studied drugs with sulphanilic acid (SPA) in presence of potassium chromate (K2Cr04)
In the present study, the investigator reports the successful utility of SPA and K2C1O4 for the spectrophotometric determination of selected drugs. The methods have been successfully applied for the determination of selected drugs in various pharmaceutical preparations. 
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K3Cr04 solution:
A stock solution of 0.25 % K2Cr04 was prepared in distilled water and was diluted as and when required.
SPA solution:
A solution of 0.5 % SPA was prepared in distilled water.
Recommended procedures
A systematic and exhaustive study was carried out on various parameters involved in the formation of coloured products (as described under results and discussion), the following procedures were recommended for the assay of Calibration curves were constructed and used for computing the amounts of studied drugs in various pharmaceutical preparations.
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Analysis of pharmaceutical preparations:
Tablets: 
Spectral characteristics:
Following the recommended procedures, the oxidative coupled products were developed and subjected to scanning on a spectrophotometer in the
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wavelength region of 360 -800 nm. The coloured products exhibited absorption maxima at 560 nm for PC, at 490 nm for MD, and at 495 nm for LD and DPH
where the corresponding reagents blank did not absorb ( Fig. 3.1a) . Hence, these wavelengths were selected for all subsequent measurements.
Standardization of experimental parameters:
The optimum conditions for the proposed procedure were performed by systematic investigations. This was necessary for rapid formation of the coloured product of maximum stability and sensitivity. 
Effect of K2Cr04 on the sensitivity of the coloured product:
Optimization of SPA concentration:
The effect of SPA on the formation of coloured species was studied by keeping the concentration of each drug and K2Cr04 fixed and measuring the absorbances at respective values. It was found that 1.0-2.0 ml (for PC), 4-6 ml (for LD), 3.0-5.0 ml (for MD) and 2-3 ml (for DPH) of 0.5 % SPA gave coloured products of maximum stability and sensitivity. Further, it was noticed that the intensity of the products decreased below these volumes of SPA However, the addition of excess of SPA produced no adverse effects on absorbance values ( Fig. 3.1f ). Hence, 1.5 ml, 5.0 ml, 2.5 ml and 4.0 ml of 0.5 % SPA for PC, LD, DPH and MD respectively were used in a total volume of 10 ml for subsequent work.
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Sequence of addition of reagents:
To achieve coloured products of optimum absorbance, the reactants were added in all possible sequences. It was found that the order of addition of the reagents was critical and hence, the order suggested in the procedure was followed.
Precision and accuracy of the proposed method:
The precision of the proposed method was ascertained from absorbance values obtained by actual determination of six replicates of fixed amount of the bulk sample of each drug. The low values of percentage relative standard deviation recorded in Table 3 .1b indicate good precision of the method.
To determine the accuracy of the proposed method, different amounts of bulk samples of catecholamines were taken within the Beer's law limits and analyzed. The percentage errors at 95 % confidence limits were calculated and are given in Table 3 .1b.
Optical characteristics of the coloured products:
In order to examine whether the oxidative coupled products formed in the proposed method adhere to Beer's law or not, the absorbances of a series of solutions containing increased amounts of each drug were measured against the corresponding reagent blank at respective >.max values. A linear relationship was found between the absorbance at X^ and the concentration of coloured species in the concentration ranges of 1-16 ppm for PC, 1-23 ppm for LD, 1.5-40 ppm for MD and 2-11 ppm for DPH ( Fig. 3.1g ). Regression analyses of Beer's law plots at their respective X^ values revealed a good correlation. The optimum photometric range, molar absorptivity and Sandell's sensitivity values have been evaluated and the results are tabulated in Table 3 .1b.
Effect of temperature on coloured products:
The effect of temperature on coloured products was studied. The results indicated that the absorbance values remained constant in die temperature range 15-40°C. Above 40°C, the absorbance values gradually decreased indicating the dissociation of the products. The coloured products were stable for more than 7-8 h at room temperature and hence make the method more practicable for routine quality control.
Studies on the interference of excipients:
In order to assess the possible analytical applications of the proposed method, the effects of some foreign ions, which often accompany with these drugs in pharmaceutical products, were studied by adding different amounts of foreign ions to catecholamines (10 ppm of LD or PC, 8 ppm of DPH, 20 ppm of MD). The colour was developed following the procedure described earlier.
An ion/substance was considered to be interfered with the determination if the obtained absorbance values differed by more than ±2% from that for the drug alone. It was observed that the talc, glucose, starch, lactose, sulphate, dextrose, acetate, phosphate and magnesium stearate did not interfere in the determination of above catecholamines at the levels found in dosage forms. It was also found that the antioxidant (sodium metabisulphite) and sodium chloride, which are commonly present in dopamine injection, did not interfere. Thus, the proposed method is free from interferences by various substances and ions.
Recovery studies:
To determine the accuracy and reproducibility of the proposed method, recovery experiments were performed using the method of addition. A fixed amount of pure sample solution was added to four solutions of different concentrations of the standard drug. The total amount of drug was then determined and amount of the added drug was calculated by the difference. The results were observed to be in good agreement.
Applicability of the proposed method:
The utility of the proposed method for the assay of pharmaceutical preparations marketed under different trade names was examined. The results of assay of tablets and injections of studied drugs summarized in Table 3 .1c
compare favorably with the quoted values and those values obtained by the reported method.
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Statistical analysis of the results in comparison with the reported method14:
The results of analysis of tablets and injections were compared statistically by the Student t-test and by the variance ratio F-test with those obtained by the reported method. The Student t-values at 95 % confidence level did not exceed the theoretical value, indicating that there was no significant difference between the proposed and reported methods. It was also noticed that the variance ratio F-values calculated for p = 0.05 did not exceed the theoretical value, indicating that there was no significant difference between the precision of the proposed and the reported method. The results are shown in Table 3 .1c.
CONCLUSIONS
The 
Abstract
A simple and accurate spectrofluorimetric method has been described for the determination of dopamine hydrochloride (DPH), levodopa (LD) and methyldopa (MD) in pure and pharmaceutical preparations. The method is based on the formation of fluorescent species due to the interaction of DPH, LD and MD with m-aminophenol (MAP) in alkaline medium. The fluorescence intensities were measured at 462 nm, at 459 nm and at 460 nm after excitation 413 nm, at 409 nm and at 429 nm for DPH, LD and MD respectively. The fluorescence intensities were found to increase linearly with concentration of DPH, LD and MD over the ranges of 0. 
EXPERIMENTAL
Standard drug solutions:
Stock solutions of DPH, LD and MD were prepared separately in distilled water, standardized and stored as discussed in Section 1. They were diluted as and when needed.
MAP solution:
A solution of 0.1 % MAP was prepared by dissolving first in a few drops of acetone and then diluting to 100 ml with distilled water.
NaOH solution:
An aqueous solution of 0.2 % NaOH was used in the study.
Recommended procedures
After a systematic and detailed study of various parameters involved in the formation of fluorescent species (as described under results and discussion).
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the following procedures were recommended for the determination of DPH, II) and MD in pure and pharmaceutical preparations.
Analysis of bulk samples:
An aliquot of standard solution containing 1-40 pg of DPH, 2-150 pg of LD and 2-120 pg of MD were transferred into a series of 10 ml volumetric flasks. To each of these were added 2.5 ml, 2.0 ml and 1.0 ml of MAP followed by 0.5 ml, 1.0 ml and 1.0 ml of NaOH for DPH, LD and MD respectively. The contents of the flasks were mixed well, diluted up to the mark with distilled water and kept for 15 min. The fluorescence intensities of the resultant products were measured at 462 nm, at 459 nm and at 460 nm after exciting at 413 nm at 409 nm and at 429 nm for DPH, LD and MD respectively.
Analysis of pharmaceutical preparations:
Tablets'.
Twenty tablets of LD and MD were weighed and powdered. An amount equivalent to 25 mg of the drug was weighed accurately and transferred into a 100 ml beaker. Using a mechanical stirrer, the powder was complete!} disintegrated and filtered. The filtrate was made upto 100 ml with distilled water and mixed well. An aliquot of the solution was analyzed using the procedure described earlier for pure drug.
Injection'.
After DPH injection solutions were appropriately diluted with distilled water to obtain the required concentration of the drug, an aliquot was taken and analyzed using the procedure described earlier.
RESULTS AND DISCUSSION
During the course of the study, it was observed that DPH, LD and MD reacted with MAP in basic medium to yield corresponding fluorophores at room temperature. The attempts to characterize the fluorophores were failed as these fluorophores couldn't be extracted into any organic solvent or isolated in solid form.
The formation of fluorophores may probably be represented as Fig. 3.2a) . The corresponding was subsequently used to excite the respective fluorophore.
The emission wavelength of each fluorophore was determined by exciting the fluorophore at respective lmax value. These emission wavelengths were found to be at 462 nm, 459 nm and 460 nm for DPH, LD and MD respectively ( Fig. 3.2b) .
Optimum reaction conditions:
The optimum reaction conditions for the proposed method were achieved by measuring the emission intensities of a series of solutions by varying one and keeping other parameters fixed at corresponding wavelength of maximum emission.
Effect of reagent'.
By experiments, it was noticed that an optimum volume range of LD and MD respectively was used for the study (Fig. 3.2c ).
Effect of alkali'.
The fluorescent products were formed only in alkaline medium. Several bases viz., NaOH, KOH, NH3> ammonia buffers of different pH and Na2COwere examined to achieve fluorophores of maximum sensitivity and stability.
The fluorescence intensities were observed to be low in KOH, NH3i ammonia buffers trad Na2C03 when compared to those in NaOH. Further, it was noticed that the optimum fluorescence intensities were observed with 0.5 ml for DPH and with 1.0 ml of 0.2 % NaOH for LD and MD (Fig. 3.2d) .
Sequence of addition of reagents:
The order of addition of reagents was found to be critical and hence NaOH was added after the addition of MAP to the drug solution as suggested in the procedure.
Precision and accuracy:
The precision and accuracy of the proposed method were judged by analyzing five replicates of 3 ppm of DPH and 5 ppm of LD and MD. The precision and accuracy of the proposed method were found to be excellent as indicated from their low percentage relative standard deviation (0.65-1.18) and
percentage error at 95 % confidence limit values (0.57-0.69).
Analytical features:
Stability of the fluorophores:
The fluorophores of DPH, LD and MD were found to be stable for more than 60 min at room temperature, which make the method more practicable.
Studies of interferences of excipients and diluents:
In order to assess the possible analytical applications of the proposed method, the effects of some diluents and excipients that often accompany DPH.
LD and MD in various pharmaceutical products were studied by adding different amounts of these substances to known amounts (within working ranges) of DPH, LD and MD. The substance was considered to interfere with the determination,
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if the obtained fluorescence intensity values differed by more than ± 2.0 % from that for pure drug alone. It was found that the method did not suffer from any interference by the usual tablet diluents and excipients viz., talc, sucrose, The applicability of the proposed method was checked by analyzing DPH, LD and MD in tablets and injections. The results presented in Table 3 .
were compared statistically by the Student t-test and by the variance ratio F-test with
those of reported method8. The calculated Student t-values at 95 % confidence level did not exceed the theoretical value indicating that there was no significant difference between the proposed and reported methods. It was also noticed that the variance ratio F-values calculated for p = 0.05 did not exceed the theoretical value thereby indicating that there was no significant difference between the precision of the proposed and reported methods.
Chapter III, section 2 56
CONCLUSIONS
The proposed spectrofluorimetric method offers distinct advantages of simplicity, accuracy and sensitivity. The fluorophores formed are adequately stable for a sufficient interval of time, which make the method more practicable.
The reagents utilized in the proposed method are cheaper and easily available.
The method does not involve any critical reaction conditions or tedious sample ¥ preparation. Moreover, the proposed method has advantages over the reported methods1'8, which are either time bound or lengthy or require heating or necessarily involve an antioxidant to stabilize the fluorophore. The wide applicability of the proposed method has been well demonstrated by analyzing different pharmaceutical preparations. Moreover, the method is free from interference by common excipients. Statistical analysis of the results also showed that the proposed method has good precision and accuracy. These merits in addition to the use of simple reagents, suggest their utility for routine quality control in pharmaceutical industries. 
